Related Experiment Video

Updated: Aug 11, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Protein expression pattern in experimental pneumococcal meningitis

Matthias Klein1, Robert Paul, Barbara Angele

  • 1Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilian University, Marchioninistrasse 15, 81377 Munich, Germany.

Microbes and Infection
|February 21, 2006
PubMed

Insights

This study reveals novel protein expressions in experimental pneumococcal meningitis using protein arrays. New factors identified may play crucial roles in disease progression and treatment strategies.

Area of Science:

  • Neuroscience
  • Immunology
  • Microbiology

Background:

  • Pneumococcal meningitis is a severe infection with significant neurological consequences.
  • Understanding the host's inflammatory response is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate cytokine and protein expression patterns in experimental pneumococcal meningitis.
  • To identify novel proteins involved in the acute and later stages of the disease.

Main Methods:

  • Intracisternal infection of mice with Streptococcus pneumoniae.
  • Ceftriaxone treatment initiated 24 hours post-infection.
  • Protein array analysis of mouse brain tissue at various time points.
  • ELISA validation for selected proteins (CXCL16, IGFBP3).

Main Results:

  • Marked elevation of known meningitis-relevant cytokines (IL-1beta, IL-6, KC, MIP-2, MCP-1/CCL2) in infected mice.
  • Identification of novel proteins during acute infection: XCL-1, CCL9, CCL12, CXCL10, CXCL16, IGFBP3.
  • Upregulation of T-cell related proteins (CCL1, CXCL4, CXCL13) and IL-4 during later stages.
  • ELISA confirmed protein array findings for CXCL16 and IGFBP3.

Conclusions:

  • Protein array technology significantly expands the understanding of protein expression in pneumococcal meningitis.
  • Several newly identified proteins may represent novel therapeutic targets or biomarkers for pneumococcal meningitis.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...